Fidaxomicin "Chaser" Regimen Following Vancomycin for Patients With Multiple Clostridium difficile Recurrences

被引：32
|
作者：
Johnson, Stuart [1 ,2 ]
Gerding, Dale N. [1 ,2 ]
机构：
[1] Hines Vet Affairs Hosp, Chicago, IL USA
[2] Loyola Univ Chicago, Stritch Sch Med, Maywood, IL USA
来源：
CLINICAL INFECTIOUS DISEASES | 2013年 / 56卷 / 02期
关键词：
D O I：
10.1093/cid/cis833
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：309 / U167
页数：2
相关论文
共 50 条
  • [1] A Tapered-pulsed Fidaxomicin Regimen Following Treatment in Patients With Multiple Clostridioides difficile Infection Recurrences
    Skinner, Andrew M.
    Tan, Xing
    Sirbu, Benjamin D.
    Danziger, Larry H.
    Gerding, Dale N.
    Johnson, Stuart
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (06) : 1107 - 1109
  • [2] Fidaxomicin versus Vancomycin for Clostridium difficile Infection
    Louie, Thomas J.
    Miller, Mark A.
    Mullane, Kathleen M.
    Weiss, Karl
    Lentnek, Arnold
    Golan, Yoav
    Gorbach, Sherwood
    Sears, Pamela
    Shue, Youe-Kong
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (05): : 422 - 431
  • [3] Novel Fidaxomicin Treatment Regimens for Patients With Multiple Clostridium difficile Infection Recurrences That Are Refractory to Standard Therapies
    Soriano, Melinda M.
    Danziger, Larry H.
    Gerding, Dale N.
    Johnson, Stuart
    OPEN FORUM INFECTIOUS DISEASES, 2014, 1 (02):
  • [4] Assessment of Clostridium difficile Burden in Patients Over Time With First Episode Infection Following Fidaxomicin or Vancomycin
    Housman, Seth T.
    Thabit, Abrar K.
    Kuti, Joseph L.
    Quintiliani, Richard
    Nicolau, David P.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2016, 37 (02): : 215 - 218
  • [5] Relapse Versus Reinfection: Recurrent Clostridium difficile Infection Following Treatment With Fidaxomicin or Vancomycin
    Figueroa, Iris
    Johnson, Stuart
    Sambol, Susan P.
    Goldstein, Ellie J. C.
    Citron, Diane M.
    Gerding, Dale N.
    CLINICAL INFECTIOUS DISEASES, 2012, 55 : S104 - S109
  • [6] Both Fidaxomicin and Vancomycin Inhibit Outgrowth of Clostridium difficile Spores
    Allen, Charlotte A.
    Babakhani, Farah
    Sears, Pam
    Ly Nguyen
    Sorg, Joseph A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (01) : 664 - 667
  • [7] Review: Fidaxomicin is better than vancomycin for Clostridium difficile recurrence
    Pegues, David A.
    ANNALS OF INTERNAL MEDICINE, 2012, 156 (08)
  • [8] Proteomic Signatures of Clostridium difficile Stressed with Metronidazole, Vancomycin, or Fidaxomicin
    Maass, Sandra
    Otto, Andreas
    Albrecht, Dirk
    Riedel, Katharina
    Trautwein-Schult, Anke
    Becher, Doerte
    CELLS, 2018, 7 (11)
  • [9] Clostridium difficile-associated diarrhea in cancer patients treated with fidaxomicin or vancomycin.
    Cornely, Oliver A.
    Miller, Mark
    Fantin, Bruno
    Mullane, Kathleen M.
    Kean, Yin
    Gorbach, Sherwood
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [10] Resolution of Clostridium difficile-Associated Diarrhea in Patients With Cancer Treated With Fidaxomicin or Vancomycin
    Cornely, Oliver A.
    Miller, Mark A.
    Fantin, Bruno
    Mullane, Kathleen
    Kean, Yin
    Gorbach, Sherwood
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (19) : 2493 - +
12345